Could SNPs predict Cisplatin toxicity? (2018)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- Subjects: BIOMARCADORES; POLIMORFISMO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: American Association of Pharmaceutical Scientists
- Publisher place: Arlington
- Date published: 2018
- Source:
- Título: Abstracts
- Conference titles: AAPS PharmSci
-
ABNT
CURSINO, Maria Aparecida et al. Could SNPs predict Cisplatin toxicity? 2018, Anais.. Arlington: American Association of Pharmaceutical Scientists, 2018. . Acesso em: 24 fev. 2026. -
APA
Cursino, M. A., Quintanilha, J. C. de F., Visacri, M. B., Vaz, C. de O., Guarnieri, J. P. de O., Bastos, L. B., et al. (2018). Could SNPs predict Cisplatin toxicity? In Abstracts. Arlington: American Association of Pharmaceutical Scientists. -
NLM
Cursino MA, Quintanilha JC de F, Visacri MB, Vaz C de O, Guarnieri JP de O, Bastos LB, Torso N de G, Hirata MH, Hirata RDC, Lima CSP, Moriel P. Could SNPs predict Cisplatin toxicity? Abstracts. 2018 ;[citado 2026 fev. 24 ] -
Vancouver
Cursino MA, Quintanilha JC de F, Visacri MB, Vaz C de O, Guarnieri JP de O, Bastos LB, Torso N de G, Hirata MH, Hirata RDC, Lima CSP, Moriel P. Could SNPs predict Cisplatin toxicity? Abstracts. 2018 ;[citado 2026 fev. 24 ] - Ultrassequenciamento exômico dos genes LDLR, APOB, PCSK9 e APOE em pacientes com hipercolesterolemia familiar
- miR-183-5P e miR-421 como biomarcadores epigenéticos precoces da Síndrome Metabólica
- Involvement of TLR2 and TLR4, Chlamydophila pneumoniae and mycoplasma pneumoniae in adventitial inflammation of aortic atherosclerotic aneurysm
- Interferon-'alfa' receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-a therapy of patients with chronic hepatitis C
- Atorvastatina regula negativamente la expresión de microRNAs en individuos hipercolesterolémicos
- IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus
- Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus
- Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina
- Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
